US Pharma MarketingNYU's Neil Vasan departs as acting chair of FDA's cancer drug advisory panel
Neil Vasan, acting chair of the FDA's Oncologic Drugs Advisory Committee, told Endpoints News that he's stepped down from the committee. He's participated in 22 ODAC meetings, chairing six. Vasan's departure leaves the already short-handed ...
Neil Vasan, acting chair of the FDA's Oncologic Drugs Advisory Committee, told Endpoints News that he's stepped down from the committee. He's participated in 22 ODAC meetings, chairing six.
Vasan's departure leaves the already short-handed ...
Source: Endpoints News